BI-1245.48

Study Sponsor: Boehringer Ingelheim

Study Title

12 Week Efficacy and Safety Study of Empagliflozin (BI 10773) in Hypertensive Patients With Type 2 Diabetes Mellitus

Medicine or Vaccine (generic name)

empagliflozin

Sponsor Identification Number

1245.48

Trial Registry Identification Number(#'s)

NCT01370005

Medical Condition

Diabetes Mellitus, Type 2; Hypertension

Phase

Phase 3

Link to study details on the BI Clinical Study Register

Link to study details on ClinicalTrials.gov (if available)

Link to study details on EudraCT (if available)

Datasets and Documents Available for this Study

Raw dataset	Annotated case report form	Dataset specifications	Protocol with any amendments
Analysis-ready dataset	Reporting and analysis plan	Clinical study report	Ready to Share

Additional information about the data and documents available for this study

Date Added to this Site

December 2014